글로벌 자동 분사기 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

자동 분사기 시장 분석

자동 주사기는 아나필락시스를 예방하기 위해 에피네프린을 자가 투여하고, 편두통 환자의 즉각적인 통증 완화와 의료 및 응급 치료를 위해 사용됩니다. 아나필락시스 발생률의 증가는 자동 주사기 시장의 성장을 가속화하고 있습니다.

자동 분사기 시장 규모

글로벌 자동 분사기 시장 규모는 2023년에 830억 5천만 달러로 평가되었으며, 2031년까지 4,014억 8천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 21.77%입니다.

보고 범위 및 시장 세분화       

자동 분사기 시장 정의

An auto injector refers to a syringe with a spring-charged needle that has a pre-charged dosage of drugs. A measured dosage of a drug is triggered and administered when pressed into the body with a sliding motion. Auto-injectors offer various advantages such as, reducing needle-related phobia disorder, and risks of needle stuck accidents, among others.

Auto Injectors Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Prevalence of Targeted Therapies

The increase in the prevalence of targeted therapies, such as alemtuzumab (certain chronic leukemias), and trastuzumab (certain breast cancers), among others acts as one of the major factors driving the growth of auto injectors market.

• Funds and Grants

The surge in investments in the form of funds and grants for therapies associated with auto injectors accelerate the market growth.

• Favorable reimbursements

The presence of favorable reimbursements and increasing government support further influence the auto injectors market.

Opportunities

Furthermore, patent expiry of biologics to drive the demand for biosimilars extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, increasing the preference for self-administration will further expand the auto injectors market.

Restraints/Challenges Global Auto Injectors Market

On the other hand, increase in the preference for alternative drug delivery modes and development of nasal epinephrine sprays are expected to obstruct market growth. Also, development of autoinjectors for multiple drug viscosities and lack of proper training for using auto injectors are projected to challenge the auto injectors market in the forecast period of 2024-2031.

This auto injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on auto injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Auto Injectors Market Scope

The auto injectors market is segmented on the basis of therapy, type, end- users, route of administration, molecule, design and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Therapy

• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Anaphylaxis
• Other Therapies

Type

• Disposable Auto Injectors
• Reusable Auto Injectors

End- Users

• Home Care Settings
• Hospitals and Clinics
• Ambulatory Surgical Centers

Route of Administration

• Subcutaneous
• Intramuscular

Type of Molecule

• Monoclonal Antibody
• Peptide
• Protein
• Small Molecule

Design

• Standardized
• Customized

Product

• Prefilled
• Fillable

Auto Injectors Market Regional Analysis

The auto injector market is analysed and market size insights and trends are provided by country, therapy, type, end- users, route of administration, type of molecule, design and product as referenced above.

The countries covered in the auto injector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the auto injector market because of the advancements in medical devices technologies and advanced healthcare infrastructure within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing incidence of diabetics and anaphylaxis due to food allergies in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The auto injector market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto injector market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto injector market. The data is available for historic period 2010-2020.

Auto Injectors Market Share

자동 주입기 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 자동 주입기 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 자동 분사기 시장 리더는 다음과 같습니다.

• AbbVie Inc.(미국)
• 마일런 NV(미국)
• 릴리. (미국)
• 암젠 주식회사(미국)
• Ypsomed Holding(스위스)
• BD(미국)
• 오웬 멈포드 유한회사(영국)
• Consort Medical, Plc. (영국)
• SHL Medical AG(스위스)
• 존슨 메드텍, LLC. (미국)
• Teva Pharmaceuticals USA, Inc. (미국)
• 안타레스 파마(뉴저지)
• 아스트라제네카(영국)
• Union Medico Inc. (덴마크)
• Gerresheimer AG(독일)
• West Pharmaceutical Services, Inc(미국)
• 신흥. (미국)

자동 분사기 시장의 최신 동향

• Antares Pharma(미국)는 2020년 8월 Lunatus Global Medical Supplies(두바이)와 계약을 맺었습니다. Antares는 계약에 따라 Lunatus에 포장 제품을 공급할 것으로 예상됩니다. Lunatus는 UAE와 사우디아라비아에서 XYOSTED에 대한 규제 승인을 제출하고 획득하며, 이 두 국가에서 XYOSTED를 홍보, 마케팅 및 유통할 것입니다.

SKU-25580